夏琳｜厦门大学｜学者主页

2026

非编码RNA在造血干细胞移植后GVHD中的多维调控与临床转化

冯一梅，古育玲，夏琳，杨世杰，张曦

《检验医学与临床》

2024

Ern1调控肿瘤免疫原性机制的初步探索

李莫寒，夏琳，马瑜婷

《中国免疫学杂志》

2024

ADAR1介导的RNA编辑在血液肿瘤中的调控作用

万星煜，郭焕平，黄瑞昊，王筱淇，曾令宇，吴涛，夏琳，张曦

《生物化学与生物物理进展》

DOI

2023

Data from Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition

Xia Lin, Zaozao Zheng, Junyi Liu, Yujie Chen, Jiancheng Ding, Guosheng Hu, Ya-hong Hu, Suling Liu, Wenxin Luo, Ningshao Xia, Wen Liu

DOI

2023

A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19

Lin Xia, Lunzhi Yuan, Ya-hong Hu, Junyi Liu, Guo-Sheng Hu, Ruoyao Qi, Tian-ying Zhang, Hualong Xiong, Zaozao Zheng, Hong-wei Lin, Jiamo Zhang, Chao Yu, Ming Zhou, Jian Ma, Tong Cheng, Ri-rong Chen, Yi Guan, Ningshao Xia, Wen Liu

Cellular and Molecular Immunology

DOI

2022

Super-enhancer-controlled positive feedback loop BRD4/ERα–RET–ERα promotes ERα-positive breast cancer

Zaozao Zheng, Lin Xia, Guo-Sheng Hu, Junyi Liu, Ya-hong Hu, Yu-jie Chen, Peng Jia-yin, Wenjuan Zhang, Wen Liu

Nucleic Acids Research

DOI

2021

BRD4 inhibition boosts the therapeutic effects of epidermal growth factor receptor-targeted chimeric antigen receptor T cells in glioblastoma

Lin Xia, Junyi Liu, Zaozao Zheng, Yu-jie Chen, Jian‐cheng Ding, Ya-hong Hu, Guo-Sheng Hu, Ningshao Xia, Wen Liu

Molecular Therapy

DOI

2021

Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition

Lin Xia, Zaozao Zheng, Junyi Liu, Yu-jie Chen, Jian‐cheng Ding, Guo-Sheng Hu, Ya-hong Hu, Suling Liu, Wenxin Luo, Ningshao Xia, Wen Liu

Cancer Immunology Research

DOI

2020

表观遗传学修饰在血液肿瘤中的研究进展

杨程，夏琳，赫童，苟阳，唐永杰，彭贤贵，张曦，张云芳

《生物化学与生物物理进展》

DOI

2020

EGFR‐targeted CAR‐T cells are potent and specific in suppressing triple‐negative breast cancer both in vitro and in vivo

Lin Xia, Zaozao Zheng, Jun‐yi Liu, Yu‐jie Chen, Jian‐cheng Ding, Ningshao Xia, Wenxin Luo, Wen Liu

Clinical & Translational Immunology

DOI

2017

Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy

Lin Xia, Ruopeng Su, Zhiqiang An, Tong‐Ming Fu, Wenxin Luo

Human Vaccines & Immunotherapeutics

DOI

2017

Active evolution of memory B-cells specific to viral gH/gL/pUL128/130/131 pentameric complex in healthy subjects with silent human cytomegalovirus infection

Lin Xia, Aimin Tang, Weixu Meng, Daniel C. Freed, Linling He, Dai Wang, Fengsheng Li, Leike Li, Wei Xiong, Xun Gui, Robbie D. Schultz, Hao-tai Chen, Xi C. He, Ryan Swoyer, Sha Ha, Yaping Liu, Charles D. Morris, Zhou Yu, I‐Ming Wang, Qinjian Zhao, Wenxin Luo, Ningshao Xia, Amy S. Espeseth, Daria J. Hazuda, Richard E. Rupp, Alan D.T. Barrett, Zhiqiang An, Jiang Zhu, Tong‐Ming Fu, Zhiqiang An

Oncotarget

DOI

2016

A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5

Lin Xia, Yangfei Xian, Daning Wang, Yuanzhi Chen, Xiaofen Huang, Xingjian Bi, Hai Jing Yu, Zheng Fu, Xinlin Liu, Shaowei Li, Zhiqiang An, Wenxin Luo, Qinjian Zhao, Ningshao Xia

Scientific Reports

DOI

2015

In vitroaffinity maturation and characterization of anti-P24 antibody for HIV diagnostic assay

Lin Xia, Juan Zhang, Chuanjia Cui, Xingjian Bi, Junhui Xiong, Hai Jing Yu, Zhiqiang An, Wenxin Luo, Ningshao Xia

The Journal of Biochemistry

DOI

2011

Properties and Therapeutic Efficacy of Broadly Reactive Chimeric and Humanized H5-Specific Monoclonal Antibodies against H5N1 Influenza Viruses

Qingbing Zheng, Lin Xia, Wai Lan Wu, Zhenhua Zheng, Yongting Huo, Jun Fa Wu, Yanning Liu, Hai Jing Yu, Yixin Chen, Siu-Ying Lau, Honglin Chen, Wenxin Luo, Ningshao Xia

Antimicrobial Agents and Chemotherapy

DOI

夏琳

精选作品

期刊论文